|
 |
| home > pmps > summer 2003 > date and lot code inspection - evaluating optical character verification (ocv) technology |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
As the demands for greater security and traceabilty in pharmaceutical manufacturing have increased, the need for automatic verification of date and lot information has become more important than ever. The correctness of human-readable character strings, whether they appear on cartons, bottles or blister packs, need to be verified with the highest degree of accuracy and reliability, and often at exceptionally high line speeds.
Pharmaceutical manufacturers generally rely on machine vision technology for automatic date and lot code verification. In a typical application, a video camera mounted to a labeller or other piece of packaging equipment captures an image of the character string to be verified, which may or may not be printed on a label. The image is then processed using specialised OCV algorithms, which compare the read characters to a set of characters which the user previously taught the system. If an incorrect character is found, the vision system may send a fail signal to a PLC, which in turn may trigger some type of reject mechanism to eject the package from the line.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
